LIVN vs MDT
LIVN: LivaNova is a medical device company specializing in advanced therapies for cardiac surgery and neurological disorders, including epilepsy and sleep apnea. MDT: Medtronic is a global healthcare technology leader dedicated to alleviating pain, restoring health, and extending life through innovative medical devices and digital solutions.
Side-by-side fundamentals
| Metric | LIVN | MDT | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $78.44 | $93.03 | |
| Market cap | $4.3B | $119.0B | |
| P/E as of 2026-10-21 | 23.14 | 22.91 | MDT lower |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2026 | n/a | 2.35 | |
| Net margin | -17.5% | +13.2% | MDT higher |
| Gross margin FY2025, SEC XBRL | +67.7% | n/a | |
| Operating margin | +14.4% | +17.8% | MDT higher |
| ROE | -20.2% | +9.7% | MDT higher |
| ROA | -9.3% | +5.2% | MDT higher |
| Debt / equity | 0.22 | 0.56 | LIVN lower |
| Revenue growth (YoY) | +10.7% | +8.4% | LIVN higher |
| Revenue CAGR (3y) SEC XBRL | +10.8% | +5.2% | LIVN higher |
| Dividend yield as of 2026-09-03 | n/a | +3.1% | |
| Dividend streak (yrs) SEC XBRL | 0 | 14 | MDT higher |
| Beta as of 2026-09-03 | 0.94 | 0.35 | |
| 1-year return as of 2026-10-21 close | +43.4% | -2.9% | LIVN higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.